Dr. Stefano Menini is an Associate Professor of Applied Dietetic Techniques Sciences at the Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, “La Sapienza” University, Rome. He obtained, from the University of Genoa, his Master’s degree in Biological Sciences in 1995 and his Ph.D. in Biology and Pathology of Aging in 2000. He also obtained a Master’s degree in Science of Human Nutrition from the University of Rome Tor Vergata in 2003. He worked as a Research Fellow at the University of Genoa from 2000 to 2004. He joined the “La Sapienza” University as a Researcher in 2004 and became an Associate Professor in 2018. Dr. Menini has received some awards, such as the 2002 Young Researcher Award from the University of Genoa, the 2012 Francesca Podestà from the Italian
Society of Diabetology (SID), and the 2018 FFABR (Funding Fund for Basic Research Activities). He is also a member of the Italian Society of Diabetology (SID), the European Diabetic Nephropathy Study Group (EDNSG), and the European Association for the Study of Diabetes (EASD).
Dr. Giuseppe Pugliese is a Full Professor of Endocrinology at the Faculty of Medicine and Psychology,
Department of Clinical and Molecular Medicine, University of Rome “La Sapienza” and the Head of the Endocrine and Metabolic Unit at the Sant Andrea University Hospital, Rome. He received, from the University of Rome “La Sapienza”, a Degree in Medicine and Surgery with a vote 110/110 cum laude in 1978, a license for professional practice in 1979, and a Postgraduate Diploma in Internal Medicine in 1983. From 1986 to 1988, he was a Research Fellow at the Department of Pathology, Washington University School of Medicine, USA. He then obtained a Ph.D. in Endocrinological and Metabolic Sciences from the University of Rome “La Sapienza” in 1990 and a Diploma of Specialization in Endocrinology and
Reciprocal Diseases in 1992. His research interests include biochemical and molecular mechanisms of diabetic complications (particularly nonenzymatic glycation, carbonyl stress and galectin-3), long-term complications (kidney disease, cardiovascular disease, retinopathy, neuropathy, and muscle and bone
disease) and mortality in type 2 diabetes and physical activity, sedentary behavior, and exercise training in people with type 2 diabetes.
